Introduction
Merkel Cell Carcinoma - Overview
Merkel Cell Carcinoma - Therapeutics Development
Merkel Cell Carcinoma - Therapeutics Assessment
Merkel Cell Carcinoma - Companies Involved in Therapeutics Development
Merkel Cell Carcinoma - Drug Profiles
Merkel Cell Carcinoma - Dormant Projects
Merkel Cell Carcinoma - Discontinued Products
Merkel Cell Carcinoma - Product Development Milestones
Appendix

List of Tables
Number of Products under Development for Merkel Cell Carcinoma, H1 2020
Number of Products under Development by Companies, H1 2020
Number of Products under Development by Universities/Institutes, H1 2020
Products under Development by Companies, H1 2020
Products under Development by Universities/Institutes, H1 2020
Number of Products by Stage and Target, H1 2020
Number of Products by Stage and Mechanism of Action, H1 2020
Number of Products by Stage and Route of Administration, H1 2020
Number of Products by Stage and Molecule Type, H1 2020
Merkel Cell Carcinoma - Pipeline by 4SC AG, H1 2020
Merkel Cell Carcinoma - Pipeline by Amgen Inc, H1 2020
Merkel Cell Carcinoma - Pipeline by Apcure SAS, H1 2020
Merkel Cell Carcinoma - Pipeline by Arcus Biosciences Inc, H1 2020
Merkel Cell Carcinoma - Pipeline by Bavarian Nordic A/S, H1 2020
Merkel Cell Carcinoma - Pipeline by BeiGene Ltd, H1 2020
Merkel Cell Carcinoma - Pipeline by bluebird bio Inc, H1 2020
Merkel Cell Carcinoma - Pipeline by Boston Biomedical Inc, H1 2020
Merkel Cell Carcinoma - Pipeline by Bristol-Myers Squibb Co, H1 2020
Merkel Cell Carcinoma - Pipeline by Checkpoint Therapeutics Inc, H1 2020
Merkel Cell Carcinoma - Pipeline by CStone Pharmaceuticals Co Ltd, H1 2020
Merkel Cell Carcinoma - Pipeline by CytomX Therapeutics Inc, H1 2020
Merkel Cell Carcinoma - Pipeline by Dragonfly Therapeutics Inc, H1 2020
Merkel Cell Carcinoma - Dormant Projects, H1 2020
Merkel Cell Carcinoma - Discontinued Products, H1 2020

List of Figures
Number of Products under Development for Merkel Cell Carcinoma, H1 2020
Number of Products under Development by Companies, H1 2020
Number of Products by Top 10 Targets, H1 2020
Number of Products by Stage and Top 10 Targets, H1 2020
Number of Products by Top 10 Mechanism of Actions, H1 2020
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2020
Number of Products by Top 10 Routes of Administration, H1 2020
Number of Products by Stage and Top 10 Routes of Administration, H1 2020
Number of Products by Top 10 Molecule Types, H1 2020
Number of Products by Stage and Top 10 Molecule Types, H1 2020

Companies Mentioned
• 4SC AG
• Amgen Inc
• Apcure SAS
• Arcus Biosciences Inc
• Bavarian Nordic A/S
• BeiGene Ltd
• bluebird bio Inc
• Boston Biomedical Inc
• Bristol-Myers Squibb Co
• Checkpoint Therapeutics Inc
• CStone Pharmaceuticals Co Ltd
• CytomX Therapeutics Inc
• Dragonfly Therapeutics Inc
• Eli Lilly and Co
• Exelixis Inc
• Exicure Inc
• F. Hoffmann-La Roche Ltd
• Fate Therapeutics Inc
• Genexine Inc
• Harbin Gloria Pharmaceuticals Co Ltd
• ImmunityBio Inc
• Immunomic Therapeutics Inc
• Incyte Corp
• Kartos Therapeutics Inc
• Merck & Co Inc
• Merck KGaA
• Millennium Pharmaceuticals Inc
• Morphogenesis Inc
• NantKwest Inc
• Nektar Therapeutics
• NextCure Inc
• Novartis AG
• Ocellaris Pharma Inc
• OncoSec Medical Inc
• Oncovir Inc
• Ono Pharmaceutical Co Ltd
• QBiotics Ltd
• Replimune Ltd
• RHEACELL GmbH & Co KG
• Sotio AS
• Spring Bank Pharmaceuticals Inc
• Tarveda Therapeutics Inc